These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Hypersensitivity reactions to proton-pump inhibitors: Clinical presentation, diagnosis, and management. Kepil Ă–zdemir S; Bavbek S Allergy Asthma Proc; 2020 Mar; 41(2):e37-e44. PubMed ID: 32122452 [No Abstract] [Full Text] [Related]
4. Delayed-type hypersensitivity reactions induced by proton pump inhibitors: A clinical and in vitro T-cell reactivity study. Lin CY; Wang CW; Hui CR; Chang YC; Yang CH; Cheng CY; Chen WW; Ke WM; Chung WH Allergy; 2018 Jan; 73(1):221-229. PubMed ID: 28658503 [TBL] [Abstract][Full Text] [Related]
5. Life-threatening acute adverse cutaneous drug reactions. Wolf R; Orion E; Marcos B; Matz H Clin Dermatol; 2005; 23(2):171-81. PubMed ID: 15802211 [TBL] [Abstract][Full Text] [Related]
6. Stevens-Johnson syndrome and toxic epidermal necrolysis due to anticonvulsants share certain clinical and laboratory features with drug-induced hypersensitivity syndrome, despite differences in cutaneous presentations. Teraki Y; Shibuya M; Izaki S Clin Exp Dermatol; 2010 Oct; 35(7):723-8. PubMed ID: 19874350 [TBL] [Abstract][Full Text] [Related]
7. [Hypersensitivity to proton pump inhibitors]. Bergmann M; Guignard B; Ribi C Rev Med Suisse; 2012 Apr; 8(337):830-5. PubMed ID: 22594006 [TBL] [Abstract][Full Text] [Related]
8. Phenytoin-associated hypersensitivity syndrome with features of DRESS and TEN/SJS. Viera MH; Perez OA; Patel JK; Jones I; Berman B Cutis; 2010 Jun; 85(6):312-7. PubMed ID: 20666193 [TBL] [Abstract][Full Text] [Related]
10. Drug rash with eosinophilia and systemic symptoms vs toxic epidermal necrolysis: the dilemma of classification. Wolf R; Matz H; Marcos B; Orion E Clin Dermatol; 2005; 23(3):311-4. PubMed ID: 15896547 [TBL] [Abstract][Full Text] [Related]
11. Acute symptoms of drug hypersensitivity (urticaria, angioedema, anaphylaxis, anaphylactic shock). Limsuwan T; Demoly P Med Clin North Am; 2010 Jul; 94(4):691-710, x. PubMed ID: 20609858 [TBL] [Abstract][Full Text] [Related]
12. [Severe delayed drug hypersensitivity reactions]. Maniu CM; Buss G; Feldmeyer L; Spertini F; Ribi C Rev Med Suisse; 2013 Apr; 9(382):803-4, 806-11. PubMed ID: 23667969 [TBL] [Abstract][Full Text] [Related]
16. Serious and life-threatening drug eruptions. Manders SM Am Fam Physician; 1995 Jun; 51(8):1865-72. PubMed ID: 7762478 [TBL] [Abstract][Full Text] [Related]
17. Approach to the patient with a suspected drug eruption. Cotliar J Semin Cutan Med Surg; 2007 Sep; 26(3):147-54. PubMed ID: 18070681 [TBL] [Abstract][Full Text] [Related]
18. Clinical Phenotypes of Severe Cutaneous Drug Hypersensitivity Reactions. Guvenir H; Arikoglu T; Vezir E; Misirlioglu ED Curr Pharm Des; 2019; 25(36):3840-3854. PubMed ID: 31696807 [TBL] [Abstract][Full Text] [Related]